Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
43.90
+0.46 (1.06%)
Dec 11, 2025, 12:23 PM EST - Market open
Xenon Pharmaceuticals Employees
As of December 31, 2024, Xenon Pharmaceuticals had 327 total employees, including 316 full-time and 11 part-time employees. The number of employees increased by 68 or 26.25% compared to the previous year.
Employees
327
Change (1Y)
68
Growth (1Y)
26.25%
Revenue / Employee
$22,936
Profits / Employee
-$936,801
Market Cap
3.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 327 | 68 | 26.25% |
| Dec 31, 2023 | 259 | 46 | 21.60% |
| Dec 31, 2022 | 213 | 60 | 39.22% |
| Dec 31, 2021 | 153 | 24 | 18.60% |
| Dec 31, 2020 | 129 | 25 | 24.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XENE News
- 20 hours ago - Xenon Pharmaceuticals Inc. (XENE) Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation Transcript - Seeking Alpha
- 6 days ago - Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 - GlobeNewsWire
- 6 days ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025 - GlobeNewsWire
- 16 days ago - Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025 - GlobeNewsWire
- 5 weeks ago - Xenon to Present at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Xenon Pharmaceuticals Inc. (XENE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Xenon Reports Third Quarter 2025 Financial Results & Business Update - GlobeNewsWire